“…PE is associated with placental dysfunction, oxidative stress [1,89], dyslipidaemia [16,90] and endothelial cell activation, and is a major cause of maternal and fetal morbidity and mortality [88] A proatherogenic lipid profile, characterized by increased TG levels with reduced HDL concentration [90,91] and increased small, dense LDL particles [90] has been described. In contrast other studies demonstrated a dominance of buoyant LDL-1 and a significant decreased of small, dense LDL, namely LDL-5 and LDL-6 [92]. Notwithstanding, it has been suggested that an abnormal lipid metabolism may not only be a manifestation of PE, but dyslipidaemia may play an essential role in its pathogenesis Apart from genetic predisposition, the second group of disorders associated with an increased risk of PE includes a variety of chronic conditions such as dyslipidaemia, diabetes mellitus, hypertension, renal diseases, and various thrombophilias [93].…”